Nasdaq Sheds 1.65% as Russell 2000 Sinks to RSI 28, Oil Climbs While Gold and Silver Slide
The Nasdaq Composite dropped 1.65% to 26,755.24, with the Russell 2000 falling to an RSI of 28.3. Gold and silver declined, while oil rose. RTX secured a $6.3B contract, Lockheed Martin unveiled a new interceptor, Eli Lilly shared trial data, and Alimentation Couche-Tard agreed to acquire retail assets from Irving Oil. IBM advanced in DARPA's Quantum Benchmarking Initiative.
How this was made
The 30-second read
Why it matters
Provides fresh contract and trial data that could influence short‑term pricing for the named companies.
Market read
While the broader market fell, these company-specific announcements offer isolated upside catalysts.
What to watch
Potential supply‑chain constraints for missile production could temper upside.
Background
The article is a market commentary summarizing recent corporate releases and index moves on Oct 14 2026.
Ticker impact
RTX secured a up-to-$6.3 billion five‑year missile contract, a fresh revenue catalyst.
potential upward pressure from contract win
New multi‑billion defense award directly boosts earnings outlook.
Lockheed Martin unveiled its new PAC‑3 Edge interceptor, a fresh product announcement.
modest positive bias as the program could generate future sales
Product debut signals future growth but no contract value disclosed.
Eli Lilly released exploratory data from a Phase 3b psoriasis trial combining Taltz and Zepbound.
upward pressure if data are viewed as clinically meaningful
New trial biomarker results are material for the pipeline, though no regulatory decision yet.
IBM was selected for Stage C of DARPA’s Quantum Benchmarking Initiative, a notable research partnership.
little immediate price effect, slight long‑term upside
Research milestone adds narrative value but no direct revenue disclosed.
Market effects
Defense and pharma sectors gain from contract and trial news, supporting sector breadth.
U.S. equities see modest uplift in defense and biotech names.
Limited to U.S. markets; no broad macro shift.
Counterpoint
Contract wins may be priced in already; focus on execution risk.
Key entities
- companyRaytheon Technologies
Parent of RTX, awarded missile contract.
- companyLockheed Martin
Introduced new interceptor.
- companyEli Lilly
Reported Phase 3b trial data.
- companyIBM
Selected for DARPA quantum program.
